Find out what Breast Cancer Care is saying about the latest drug treatments, research papers and health policy issues.

If you’re a journalist working on a story and need an expert quote, call us on 0345 092 0807 (out of hours 07702 901 334).

Responding to a Canadian study revealing osteoporosis drug Denosumab could have a protective effect against breast cancer for post-menopausal women,...

24 October 2018

Responding to a Danish study revealing statins could lower risk of breast cancer in the opposite breast, Grete Brauten-Smith, Clinical Nurse...

24 October 2018

Responding to Theresa May’s aim to increase early detection of cancer as outlined at the Conservative Party Conference on Wednesday 3 October,...

4 October 2018

Responding to new projections about the number of women dying from breast cancer in the UK, Samia al Qadhi, Chief Executive of Breast Cancer Care,...

28 September 2018

Responding to NHS England’s Cancer Waiting Times for July 2018, Gunes Kalkan, Head of Evidence, Policy and Campaigns at Breast Cancer Care,...

13 September 2018

Responding to an announcement from Jeane Freeman MSP, Health Secretary, revealing that 1,761 women aged over 71 in Scotland were not invited for...

13 September 2018

Responding to a new online tool that could better predict the long-term risk of oestrogen receptor positive breast cancer returning and the need for...

24 August 2018

Responding to the updated draft guidance from NICE to not recommend Perjeta (pertuzumab) for routine NHS use after surgery for early HER2-positive...

17 August 2018

Responding to news that health officials are investigating concerns that adults who should have been invited for breast and bowel cancer screening...

11 August 2018